16077954|t|beta-Amyloid and interleukin-1beta induce persistent NF-kappaB activation in rat primary glial cells.
16077954|a|An increasing body of evidence suggests that beta-amyloid (Abeta) and activated glial cells play a crucial part in the pathogenesis of Alzheimer's disease (AD). Activated glial cells surrounding the senile plaques, formed by Abeta peptides, have been proposed to promote neurodegeneration by producing putatively toxic factors, including the inflammatory cytokine interleukin-1beta (IL-1beta). Elevated levels of both IL-1beta and activated nuclear factor kappaB (NF-kappaB), a key transcription factor regulating a wide variety of inflammatory genes, have been found in the brains of AD patients. In this study, we have investigated the ability of the Abeta(25-35) peptide and IL-1beta, either alone or together, in activating NF-kappaB in glial cells. Mixed primary glial cells from rat were treated with IL-1beta and/or Abeta(25-35), and NF-kappaB binding activity was analyzed by electophoretic mobility shift assay. We observed that the induction of NF-kappaB binding activity induced by either IL-1beta or Abeta(25-35) showed a peak at 30 min, and significantly declined after 2 h. The induced NF-kappaB activation persisted after 24 h and even seemed to increase in cells treated with Abeta(25-35). The activation of NF-kappaB by Abeta(25-35) was shown to be dose-dependent. In addition, Abeta(25-35) potentiated the effect of IL-1beta in a dose-dependent manner when co-stimulating the cells. The potentiating effect of Abeta(25-35) on IL-1beta-induced NF-kappaB binding activity was observed after 30 min, 2 h and 24 h, and did not significantly differ over time. A possible explanation is that when glial cells are stimulated by inflammatory factors in the presence of Abeta peptides or senile plaques, the NF-kappaB negative feedback regulation is no longer functional.
16077954	17	34	interleukin-1beta	Gene	24494
16077954	53	62	NF-kappaB	Gene	4790
16077954	77	80	rat	Species	10116
16077954	161	166	Abeta	Gene	351
16077954	237	256	Alzheimer's disease	Disease	MESH:D000544
16077954	258	260	AD	Disease	MESH:D000544
16077954	327	332	Abeta	Gene	351
16077954	373	390	neurodegeneration	Disease	MESH:D019636
16077954	444	456	inflammatory	Disease	MESH:D007249
16077954	466	483	interleukin-1beta	Gene	24494
16077954	485	493	IL-1beta	Gene	3553
16077954	520	528	IL-1beta	Gene	24494
16077954	566	575	NF-kappaB	Gene	4790
16077954	634	646	inflammatory	Disease	MESH:D007249
16077954	687	689	AD	Disease	MESH:D000544
16077954	690	698	patients	Species	9606
16077954	755	767	Abeta(25-35)	Gene	54226
16077954	780	788	IL-1beta	Gene	24494
16077954	830	839	NF-kappaB	Gene	4790
16077954	887	890	rat	Species	10116
16077954	909	917	IL-1beta	Gene	24494
16077954	925	937	Abeta(25-35)	Gene	54226
16077954	943	952	NF-kappaB	Gene	4790
16077954	1057	1066	NF-kappaB	Gene	4790
16077954	1102	1110	IL-1beta	Gene	24494
16077954	1114	1126	Abeta(25-35)	Gene	54226
16077954	1202	1211	NF-kappaB	Gene	4790
16077954	1294	1306	Abeta(25-35)	Gene	54226
16077954	1326	1335	NF-kappaB	Gene	4790
16077954	1339	1351	Abeta(25-35)	Gene	54226
16077954	1397	1409	Abeta(25-35)	Gene	54226
16077954	1436	1444	IL-1beta	Gene	24494
16077954	1530	1542	Abeta(25-35)	Gene	54226
16077954	1546	1554	IL-1beta	Gene	24494
16077954	1563	1572	NF-kappaB	Gene	4790
16077954	1741	1753	inflammatory	Disease	MESH:D007249
16077954	1781	1786	Abeta	Gene	351
16077954	1819	1828	NF-kappaB	Gene	4790
16077954	Positive_Correlation	MESH:D000544	24494
16077954	Association	MESH:D000544	351
16077954	Association	MESH:D000544	4790
16077954	Positive_Correlation	351	3553
16077954	Positive_Correlation	24494	4790
16077954	Association	MESH:D007249	351
16077954	Positive_Correlation	4790	54226
16077954	Association	MESH:D007249	4790
16077954	Association	24494	54226
16077954	Association	MESH:D007249	3553

